Prostate cancer outcomes: The three questions - Abstract

Enhanced survival and therapeutic choices for men with prostate cancer mandate the evaluation of the "quality of survival".

An exciting series of local, national and international health outcome improvement initiatives offer the enticing prospect of assessing and improving this.

Written by:
Glaser AW, Corner JL.   Are you the author?
Leeds Teaching Hospitals NHS Trust, Leeds Institute of Cancer and Pathology, Leeds, UK; Faculty of Health Sciences, Southampton University, Southampton, UK; Macmillan Cancer Support, London, UK.  

Reference: Eur Urol. 2014 Nov 10. pii: S0302-2838(14)01037-9.
doi: 10.1016/j.eururo.2014.10.023

 
PubMed Abstract
PMID: 25454610

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe